Research Article
Expression Profiling of Cellular MicroRNA in Asymptomatic HBsAg Carriers and Chronic Hepatitis B Patients
Table 2
Clinical data of patients used for cellular miRNA analysis.
| Clinical characteristics | HC | ASC | CHB | value |
| Number of patients | 16 | 16 | 16 | = NS | Sex number (%) | | | | | Female | 6 | 5 | 6 | | Male | 10 | 11 | 10 | = NS | Age (years) | | | | | Median | 45 | 43 | 42 | | Range | 34–65 | 27–64 | 25–62 | = NS | ALT | | | | = NS (ASC versus HC ) | Median | 27.43 | 34.38 | 95.36 | 0.001 (CHB versus HC) | Range | 9–69 | 17–89 | 16–253 | 0.001 (CHB versus ASC) | AST | | | | = NS (ASC versus HC) | Median | 24 | 35.29 | 75.50 | = 0.028 (CHB versus HC ) | Range | 14–34 | 21–84 | 9–327 | = NS (CHB versus ASC ) | HBV DNA | | | | | Median | NA | 1.51 106 | 2.70 108 | | Range | NA | 2.12 103–5.99 106 | 2.37 104–2.51 109 | = NS (CHB versus ASC) | HBsAg | | | | | HBsAg (+) | NA | 4 (25%) | 10 (62.5%) | | HBsAg (−) | NA | 12 (75%) | 6 (37.5%) | = 0.033 (CHB versus ASC) |
|
|